[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_FY_USD":210211.0,"TaxesPayableCurrent_0_FY_USD":18883.0,"StockRepurchasedAndRetiredDuringPeriodShares_4_FY_shares":null,"RepaymentsOfRelatedPartyDebt_4_FY_USD":280000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_4_FY_USD":null,"NonoperatingIncomeExpense_4_FY_USD":3745540.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":null,"ValuationAllowanceDeferredTaxAssetChangeInAmount_4_FY_USD":null,"DeferredTaxAssetsGross_0_FY_USD":1653.0,"DeferredFederalIncomeTaxExpenseBenefit_4_FY_USD":669883.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_FY_pure":0.5,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_4_FY_USD":7000000.0,"ProceedsFromIssuanceOfPrivatePlacement_4_FY_USD":7000000.0,"PrepaidExpenseCurrent_0_FY_USD":92150.0,"IncreaseDecreaseInPrepaidExpense_4_FY_USD":92150.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_4_FY_USD":null,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4_FY_USD":209656.0,"CashFDICInsuredAmount_0_FY_USD":250000.0,"InvestmentIncomeInterest_4_FY_USD":3753411.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_FY_USD":275563755.0,"ProceedsFromSaleOfTrustAssetsToPayExpenses_4_FY_USD":651000.0,"PaymentsOfStockIssuanceCosts_4_FY_USD":510867.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_4_FY_USD":18883.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_4_FY_USD":5000000.0,"DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_0_FY_USD":1653.0,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":-1653.0,"DeferredOfferingCosts_0_FY_USD":16473117.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_pure":0.0,"UnrealizedGainLossOnSecurities_4_FY_USD":-7871.0,"PaymentsToAcquireInvestments_4_FY_USD":287500000.0,"DeferredCosts_0_FY_USD":null,"OperatingCostsAndExpenses_4_FY_USD":564339.0,"NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":-217549.0,"AssetsHeldInTrustNoncurrent_0_FY_USD":290594540.0,"IncomeTaxesPaid_4_FY_USD":651000.0,"EffectiveIncomeTaxRateContinuingOperations_4_FY_pure":0.21,"CurrentStateAndLocalTaxExpenseBenefit_4_FY_USD":null,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":288839133.0,"LiabilitiesCurrent_0_FY_USD":229094.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":291605350.0,"Liabilities_0_FY_USD":11041594.0,"IncomeTaxExpenseBenefit_4_FY_USD":668230.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":3181201.0,"NetCashProvidedByUsedInInvestingActivities_4_FY_USD":-286849000.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-0.03,"CashAndCashEquivalentsPeriodIncreaseDecrease_4_FY_USD":892300.0,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":917007.0,"AssetsCurrent_0_FY_USD":1009157.0,"Assets_0_FY_USD":291605350.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4_FY_shares":21375000.0,"AdditionalPaidInCapital_0_FY_USD":2487262.0,"DueToRelatedPartiesCurrent_0_FY_USD":null,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-1097833.0,"NetIncomeLoss_4_FY_USD":2512971.0,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":null,"CurrentFederalTaxExpenseBenefit_4_FY_USD":-1653.0,"PreferredStockValue_0_FY_USD":null,"PreferredStockSharesOutstanding_0_FY_shares":null,"PreferredStockSharesIssued_0_FY_shares":null,"PreferredStockSharesAuthorized_0_FY_shares":1000000.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.0001,"OperatingIncomeLoss_4_FY_USD":-564339.0,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4_FY_pure":0.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4_FY_pure":0.21,"DeferredTaxAssetsNet_0_FY_USD":1653.0,"CommitmentsAndContingencies_0_FY_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":8015444.0,"StockholdersEquity_0_FY_USD":5000001.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":2511873.0,"ProceedsFromRelatedPartyDebt_4_FY_USD":130000.0,"StockRedeemedOrCalledDuringPeriodValue_4_FY_USD":-275563755.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_4_FY_USD":2730520.0,"Ticker":"CELU","CIK":"1752828","name":"GX ACQUISITION CORP.","OfficialName":"Celularity Inc. Class A Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1622347796.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200324"}]